Compare iShares MSCI Japan ETF (EWJ) vs Intuitive Surgical, Inc. (ISRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Japan ETF vs Intuitive Surgical, Inc. — how do they compare? iShares MSCI Japan ETF trades at $98.51, while Intuitive Surgical, Inc. trades at $400.88 (market cap $141.76B). The key difference: iShares MSCI Japan ETF is trading nearer its 52-week high, Intuitive Surgical, Inc. nearer its low. Which is the better fit depends on your goals.
| EWJ | ISRG | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $97.79 | $592.85 |
52-Week Low | $77.93 | $332.02 |
Market Cap | — | $141.76B |
Enterprise Value | — | $136.54B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWJ, the iShares MSCI Japan ETF, trades at $97.79, up 1.57% on the day, with a bullish technical signal driven by moving averages. The ETF benefits from Japan's export strength amid a weak yen but faces overbought RSI readings. Recent news highlights U.S.-Japan currency interventions and domestic economic stimulus efforts, influencing fund flows and sector performance.
The outlook remains positive due to structural reforms and foreign investment inflows, though risks include yen volatility, inflation pressures, and global tech sector sensitivity. Investors should weigh currency-hedged alternatives to mitigate FX drag, as noted in recent analysis.
Intuitive Surgical (ISRG) trades at $401.27, showing minimal daily movement with a slight 0.01% gain. The stock maintains a bullish technical trend, supported by strong fundamentals including consistent earnings beats and robust revenue growth, with 2025 revenue reaching $10.06 billion. Recent news highlights analyst upgrades and optimism around da Vinci 5 adoption, though U.S. procedure growth has slowed temporarily.
The outlook remains positive with a consensus price target of $518.10, implying significant upside. Key opportunities include expanding robotic surgery applications and high profitability margins. Risks involve competitive pressures from Medtronic and Johnson & Johnson, valuation concerns with a P/E of 46.02, and near-term procedure volatility. Institutional sentiment is strongly bullish, with 68% of analysts rating it a Buy.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares MSCI Japan ETF
EWJ tracks the MSCI Japan Index, providing broad exposure to over 180 large and mid-cap companies in Japan. It is the most established and liquid vehicle for accessing the Japanese equity market, featuring a diversified portfolio across industrials, consumer discretionary, and financial sectors.
Read more on EWJ →About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →
